OpenEMR up to 8.4.x Eye Exam Editor view.php PLAN cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00+ |
Summary
A vulnerability, which was classified as problematic, has been found in OpenEMR up to 8.4.x. This vulnerability affects unknown code of the file view.php of the component Eye Exam Editor. Performing a manipulation of the argument PLAN results in cross site scripting. This vulnerability is reported as CVE-2026-126462. The attack is possible to be carried out remotely. No exploit exists. It is advisable to upgrade the affected component.
Details
A vulnerability was found in OpenEMR up to 8.4.x. It has been classified as problematic. This affects an unknown functionality of the file view.php of the component Eye Exam Editor. The manipulation of the argument PLAN with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
OpenEMR before 8.5.0 contains a stored cross-site scripting vulnerability that allows authenticated users with Eye Exam edit permission to inject scripts via the Next Visit Orders PLAN[] field. Attackers can store a payload closing the textarea in view.php, executing JavaScript when another user opens the Eye Exam editor to steal session identifiers or clinical data.
The advisory is shared at github.com. This vulnerability is uniquely identified as CVE-2026-126462 since 11/10/2026. The exploitability is told to be easy. It is possible to initiate the attack remotely. It demands that the victim is doing some kind of user interaction. Technical details are known, but no exploit is available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
By approaching the search of inurl:view.php it is possible to find vulnerable targets with Google Hacking.
Upgrading to version 8.5.0 eliminates this vulnerability.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Name
Version
License
Website
- Product: https://github.com/openemr/openemr/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.4
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Google Hack: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: OpenEMR 8.5.0
Timeline
11/10/2026 CVE reserved11/13/2026 Advisory disclosed
11/13/2026 VulDB entry created
11/13/2026 VulDB entry last update
Sources
Product: github.comAdvisory: github.com
Status: Confirmed
CNA: VulnCheck
CVE: CVE-2026-126462 (🔒)
GCVE (CVE): GCVE-0-2026-126462
GCVE (VulDB): GCVE-100-436857
Entry
Created: 11/13/2026 11:46Changes: 11/13/2026 11:46 (78)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.